Gilead Sciences Inc. (Nasdaq: GILD) will acquire YM BioSciences Inc. (NYSE: YMI) for about $510 million.

The deal amounts to about $2.95 per share.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.